Journal of Clinical Endocrinology & Metabolism, Vol 81, 1693-1696, Copyright © 1996 by Endocrine Society

ARTICLES

Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee

SP Taback and HJ Dean
Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada.

The objective of this study was to determine the risk of death and potential for prevention of mortality in a large population of children with growth hormone deficiency (GHD). The Canadian GH Advisory Committee registry was initiated in 1967 to include all persons in Canada treated with pituitary-derived GH (1967-1985). Since 1985, the registry has been maintained for continuous surveillance of those treated with biosynthetic GH. Thirty-seven children have died out of a total of 1366 children treated for GHD in the 25 years up to December 31, 1992. Individual cases were reviewed for circumstances before death and autopsy information. The likelihood of individual deaths being caused by potentially preventable endocrine causes was graded on a scale of 1-5. Survival curves were analyzed for the children with idiopathic GHD and craniopharyngioma. Age- and sex-specific mortality rates for children with idiopathic GHD were compared with those of the general population. The overall crude mortality rate was 2.7%. The most frequent cause of mortality was tumor recurrence (11/37). A surprisingly high proportion of deaths (9/37) were caused by the preventable endocrine complications of adrenal crisis and hypoglycemia. Children with idiopathic GHD receiving GH therapy had similar age- and sex-specific mortality rates compared with general population rates, except in a high-risk subgroup of males diagnosed with GHD before 2 yr of age. The highest mortality occurred in children with GHD secondary to craniopharyngioma. We concluded that preventable sudden deaths caused by adrenal crisis continue to occur in children with hypopituitarism. A high level of vigilance must be maintained in this population.

This article has been cited by other articles:

				K. Stochholm, C. H. Gravholt, T. Laursen, P. Laurberg, M. Andersen, L. O. Kristensen, U. Feldt-Rasmussen, J. S. Christiansen, M. Frydenberg, and A. Green Mortality and GH deficiency: a nationwide study Eur. J. Endocrinol., July 1, 2007; 157(1): 9 - 18. [Abstract] [Full Text] [PDF]

				D. I. Shulman, M. R. Palmert, S. F. Kemp, and for the Lawson Wilkins Drug and Therapeutics Commi Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood Pediatrics, February 1, 2007; 119(2): e484 - e494. [Abstract] [Full Text] [PDF]

				M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al. Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry Pediatrics, April 1, 2001; 107(4): 744 - 754. [Abstract] [Full Text] [PDF]

				A. J. Swerdlow, R. E. Reddingius, C. D. Higgins, H. A. Spoudeas, K. Phipps, Z. Qiao, W. D. J. Ryder, M. Brada, R. D. Hayward, C. G. D. Brook, et al. Growth Hormone Treatment of Children with Brain Tumors and Risk of Tumor Recurrence J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4444 - 4449. [Abstract] [Full Text]

				C. L. Clarson and R. F. Del Maestro Growth Failure After Treatment of Pediatric Brain Tumors Pediatrics, March 1, 1999; 103(3): 37e - 37. [Abstract] [Full Text]

				P. V. Carroll, E. R. Christ the members of Growth Hormone Research Soci, B. A. Bengtsson, L. Carlsson, J. S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, et al. Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 382 - 395. [Abstract] [Full Text]

				N. Weintrob, E. Sprecher, Z. Josefsberg, C. Weininger, Y. Aurbach-Klipper, D. Lazard, M. Karp, and A. Pertzelan Standard and Low-Dose Short Adrenocorticotropin Test Compared with Insulin-Induced Hypoglycemia for Assessment of the Hypothalamic-Pituitary-Adrenal Axis in Children with Idiopathic Multiple Pituitary Hormone Deficiencies J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 88 - 92. [Abstract] [Full Text]

				F. I. Sharara and L. C. Giudice Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty Reproductive Sciences, January 1, 1997; 4(1): 2 - 7. [Abstract] [PDF]